Funding Opportunities

NIH Funding Opportunities

Notice to Correct Activity Code Information For NIAAA PA-18-620 Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional)
Notice NOT-AA-18-004 from the NIH Guide for Grants and Contracts
Wed, 21 Feb 2018 08:58:08 EST

Notice of Change to the Eligible Activity Codes for PA-16-013 "Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp)"
Notice NOT-AT-18-006 from the NIH Guide for Grants and Contracts
Fri, 23 Feb 2018 10:28:15 EST

Notice of expiration of PA-18-626 " NIDA Small Research Grant Program (R03 Clinical Trial Required)"
Notice NOT-DA-18-008 from the NIH Guide for Grants and Contracts
Wed, 21 Feb 2018 08:49:37 EST

Request for Proposals (RFP) Notice: Toxicological Evaluations of Potential Medications
Notice NOT-DA-18-062 from the NIH Guide for Grants and Contracts
Wed, 21 Feb 2018 08:53:51 EST

Notice of Pre-Application Webinar for PAR-17-341 National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32)
Notice NOT-GM-18-018 from the NIH Guide for Grants and Contracts
Wed, 21 Feb 2018 08:34:15 EST

Notice of NIGMS Participation in PA-18-609 Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R41/R42 Clinical Trial Not Allowed)
Notice NOT-GM-18-019 from the NIH Guide for Grants and Contracts
Fri, 23 Feb 2018 09:49:27 EST

Notice of NIGMS Participation in PA-18-610 "Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed)"
Notice NOT-GM-18-020 from the NIH Guide for Grants and Contracts
Fri, 23 Feb 2018 10:12:26 EST

Notice of Technical Assistance Webinar for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed); RFA HL-19-001 and RFA HL-19-002
Notice NOT-HL-18-598 from the NIH Guide for Grants and Contracts
Tue, 20 Feb 2018 09:54:31 EST

Notice of Availability of Administrative Supplements for Advancing Computational Modeling and Data Analytics Relevant to Mental Health
Notice NOT-MH-18-023 from the NIH Guide for Grants and Contracts
Tue, 20 Feb 2018 10:13:06 EST

Notice of Intent to Publish a Funding Opportunity Announcement for SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)
Notice NOT-NS-18-046 from the NIH Guide for Grants and Contracts
Fri, 23 Feb 2018 09:41:24 EST

Notice of Change to participation on PAR-18-514 " Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)"
Notice NOT-OD-18-125 from the NIH Guide for Grants and Contracts
Wed, 21 Feb 2018 08:26:21 EST

Advance Notice of Transition to the xTRACT System for Preparing Research Training Data Tables
Notice NOT-OD-18-133 from the NIH Guide for Grants and Contracts
Tue, 20 Feb 2018 10:04:10 EST

Notice of Change to participation on PAR-18-512 "Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)"
Notice NOT-OD-18-140 from the NIH Guide for Grants and Contracts
Tue, 20 Feb 2018 12:59:38 EST

Notice of Change to Instructions for Application Submission for PAR-18-307 "Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)"
Notice NOT-OD-18-142 from the NIH Guide for Grants and Contracts
Wed, 21 Feb 2018 10:40:42 EST

Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54)
Funding Opportunity RFA-OD-18-004 from the NIH Guide for Grants and Contracts. The ORWH and participating organizations and institutes seek applications for Specialized Centers of Research Excellence (SCORE) on Sex Differences. The Centers of Excellence will support interdisciplinary approaches to advance translational research on sex differences. Each SCORE institution should develop a research agenda bridging basic and clinical research underlying a health issue that is pertinent to improving the health of women.
Tue, 20 Feb 2018 02:09:58 EST

Limited Competition: NIH Coordination and Evaluation Center for Enhancing the Diversity of the NIH-Funded Workforce Program (U54 - Clinical Trial Not Allowed)
Funding Opportunity RFA-RM-18-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the Program Directors/Principal Investigators of the Coordination and Evaluation Center (CEC), which is currently supporting the research being performed for the Enhancing the Diversity of the NIH-Funded Workforce Program. This program, known as the Diversity Program Consortium (DPC), consists of three integrated initiatives: Building Infrastructure Leading to Diversity (BUILD), the National Research Mentoring Network (NRMN) and the CEC. The CEC will continue to organize the activities required for the attainment of program-wide goals and to measure the agreed upon hallmarks of success at the student, faculty, and institutional level. The CEC will employ and refine the processes developed in the previous funding period to assess the impact of BUILD and NRMN activities on attainment of the hallmarks. The CEC will coordinate the collection of data from the DPC, assess the data in an ongoing way, provide feedback, and facilitate an iterative process of program adjustment to maximize the research of BUILD and NRMN. The CEC should also focus on the dissemination of effective strategies for enhancing the diversity of the biomedical research workforce and for transitioning into a sustainable model for evaluating diversity enhancing programs beyond the funding cycle.
Thu, 22 Feb 2018 09:03:26 EST

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
Funding Opportunity PA-18-672 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Tue, 20 Feb 2018 10:35:59 EST

Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
Funding Opportunity PA-18-673 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support students at institutions without formal NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g., DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Applicants must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individuals potential to develop into a productive, independent physician/clinician-scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Tue, 20 Feb 2018 12:54:51 EST

Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY18 Administrative Supplement (Admin Supp - Clinical Trial Optional)
Funding Opportunity PA-18-676 from the NIH Guide for Grants and Contracts. The Office of Research on Womens Health (ORWH) announces the availability of administrative supplements to support interdisciplinary, transdisciplinary and multidisciplinary research focused on the effect of sex/gender influences at the intersection of a number of social determinants, including but not limited to: race/ethnicity, socioeconomic status, education, health literacy and other social determinants in human health and illness. This research includes preclinical, clinical and behavioral studies with the specific purpose to provide Administrative Supplements to active NIH parent grants for one year to address health disparities among women of populations in the US who are understudied, underrepresented and underreported in biomedical research. The proposed research must address an area specified within Objective 3.9 (Goal 3.0) of the NIH Strategic Plan for Research on Womens Health (http://orwh.od.nih.gov/research/strategicplan/index.asp) which states: Examine health disparities among women stemming from differences in such factors as race and ethnicity, socioeconomic status, gender identity, and urban-rural living, as they influence health, health behaviors, and access to screening and therapeutic interventions. Projects must include a focus on one or more NIH-designated health disparities populations, which include Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities (SGM). Combinations of one or more populations is also encouraged, e.g. socioeconomically disadvantaged sexual and gender minorities.
Thu, 22 Feb 2018 09:45:08 EST

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-677 from the NIH Guide for Grants and Contracts. The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States.
Fri, 23 Feb 2018 11:37:43 EST

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-678 from the NIH Guide for Grants and Contracts. The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States.
Fri, 23 Feb 2018 11:37:45 EST

Administrative Supplement for the NIBIB Research Education Programs for Residents and Clinical Fellows (Admin Supp Clilnical Trial Not Allowed)
Funding Opportunity PA-18-680 from the NIH Guide for Grants and Contracts. This FOA is to be used to request administrative supplements for awards made to PAR-12-085 and PAR-15-167 "NIBIB Research Education Programs for Residents and Clinical Fellows program". This Funding Opportunity Announcement (FOA) does not allow appointed trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.
Fri, 23 Feb 2018 12:06:26 EST

Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-669 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to provide continuing support for specific pathogen free (SPF) macaque colonies previously funded under the auspices of PAR-14-066. Breeding colonies are essential to sustain Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) research. Pedigree SPF macaques are free of certain viruses, which can confound the results of AIDS-related investigations or present a risk to the personnel who care for the animals. The SPF macaques are genetically characterized for major histocompatibility (MHC) class I types as defined MHC classes are critical in determining immune responses to HIV/AIDS infections.
Wed, 21 Feb 2018 09:44:55 EST

U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-674 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing cancer health disparities in tobacco use in the United States. Specifically, this FOA is intended to stimulate scientific inquiry focused on innovative tobacco control policies. Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use cancer health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. The long-term goal of this FOA is to reduce cancer health disparities in health outcomes thereby reducing the excess disease burden of tobacco use within these groups. Applicants submitting applications related to health economics are encouraged to consult NOT-OD-16-025 to ensure that the research projects align with NIH mission priorities in health economics research.
Wed, 21 Feb 2018 10:19:24 EST

U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-675 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing cancer health disparities in tobacco use in the United States. Specifically, this FOA is intended to stimulate scientific inquiry focused on innovative tobacco control policies. Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use cancer health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. The long-term goal of this FOA is to reduce cancer health disparities in health outcomes thereby reducing the excess disease burden of tobacco use within these groups. Applicants submitting applications related to health economics are encouraged to consult NOT-OD-16-025 to ensure that the research projects align with NIH mission priorities in health economics research.
Wed, 21 Feb 2018 10:19:20 EST

NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
Funding Opportunity PAR-18-679 from the NIH Guide for Grants and Contracts. The purpose of the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented independent physician-scientists. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIAID research support during this transition to help awardees launch competitive, independent research careers in biomedical fields and thereby help to address the national physician-scientist workforce shortage.
Fri, 23 Feb 2018 11:01:51 EST